Large Scale Identification of Osteosarcoma Pathogenic Genes by Multiple Extreme Learning Machine

Zhipeng Zhao1, Jijun Shi2, Guang Zhao3

  • 1Department of Basic Medical Sciences, Taizhou University, Taizhou, China.

Insights

Identifying osteosarcoma pathogenic genes is crucial for developing new treatments. A novel computational method, RELM, effectively identifies these genes, improving upon traditional methods for better osteosarcoma research.

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • Osteosarcoma, a bone cancer primarily affecting individuals under 20, has a stagnant 5-year survival rate despite current chemotherapy and surgery treatments.
  • The disease exhibits significant multigenomic heterogeneity, complicating the identification of effective therapeutic targets.
  • Understanding the genetic factors driving osteosarcoma is essential for advancing treatment strategies, particularly those targeting the tumor immune microenvironment.

Purpose of the Study:

  • To develop a novel, efficient computational method for identifying osteosarcoma pathogenic genes.
  • To overcome the limitations of traditional gene identification methods, such as high cost and time consumption.
  • To lay the groundwork for future research into osteosarcoma immune microenvironment-related treatments.

Main Methods:

  • Utilized known osteosarcoma-related genes and advanced computer algorithms.
  • Developed a novel method named RELM (relying on extreme learning machines).
  • Fused multiple extreme learning machines (ELM) within the RELM framework.

Main Results:

  • The RELM method demonstrated high reliability in identifying osteosarcoma pathogenic genes.
  • Achieved an Area Under the Curve (AUC) of 0.91 in 10-cross validation.
  • Obtained an Area Under the Precision-Recall Curve (AUPR) of 0.88 in 10-cross validation.

Conclusions:

  • The RELM method offers a reliable and efficient approach to identifying osteosarcoma pathogenic genes.
  • This computational strategy surpasses traditional methods in terms of cost and time efficiency.
  • The findings provide a foundation for further exploration of gene-targeted therapies and immune microenvironment treatments for osteosarcoma.

Related Concept Videos